How cystic fibrosis can manifest in the gastrointestinal system
In the February 2020 issue of Contemporary Pediatrics, Drs. Anna Reed and Darla Shores provide a briefing on the care of cystic fibrosis...
New X-Ray Technology For Better Management Of Lung Diseases
Australia: Researchers at Monash University have developed radical non-invasive X-ray technology to help diagnose, treat and manage...


Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment
A new non-invasive tool, called XV technology, allows professionals to visualize airflow in a living lungs and could help in the...


Synspira Therapeutics, CF Foundation Agree to Support Development of SNSP003 for Malabsorption Syndr
The Cystic Fibrosis Foundation has reached an agreement with Synspira Therapeutics to support the further development of SNSP003, an...


Study Describes Genetic Mechanisms Behind Embryonic Lung Cells
The researchers hope the findings could one day lead to cell replacement therapies for respiratory diseases, including chronic...
Chronic Pain, Depression, and Anxiety in the CF Community
We need to come to grips with a problem deeply affecting the cystic fibrosis community. It’s an issue that we don’t talk about much:...


Are intestinal organoids the key to developing personalized therapy for cystic fibrosis?
Intestinal organoids have been utilized to develop personalized therapy for cystic fibrosis patients. Cystic fibrosis (CF) is a rare...


New treatment kills off infection that can be deadly to cystic fibrosis patients
Credit: CC0 Public Domain A new treatment developed by researchers at Aston University and Birmingham Children's Hospital has been found...


Proteostasis On Track to Develop Organoids for Personalized Medicine Strategy for CF Patients with R
A project aimed at personalized medicine based on the use of organoids, or “mini-organs,” from cystic fibrosis (CF) patients with rare...


Raleigh biotech startup Arrevus gets FDA support for its drug treating cystic fibrosis patients
RALEIGH — Cystic fibrosis (CF) is a heredity disease with no cure. However, Raleigh biotech startup Arrevus believes it owns a drug that...

